0001209191-18-020023.txt : 20180315
0001209191-18-020023.hdr.sgml : 20180315
20180315201118
ACCESSION NUMBER: 0001209191-18-020023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180313
FILED AS OF DATE: 20180315
DATE AS OF CHANGE: 20180315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cotroneo Pat
CENTRAL INDEX KEY: 0001621334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 18693941
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS ST.,
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER NAME:
FORMER CONFORMED NAME: Controneo Pat
DATE OF NAME CHANGE: 20141002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-13
0
0000921299
FIBROGEN INC
FGEN
0001621334
Cotroneo Pat
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
0
1
0
0
VP, Finance and CFO
Common Stock
2018-03-13
4
S
0
5932
54.61
D
168334
D
Common Stock
2015-03-14
4
A
0
28000
0.00
A
196334
D
Common Stock
2018-03-15
4
M
0
14000
19.39
A
210334
D
Common Stock
2018-03-15
4
M
0
22094
29.66
A
232428
D
Common Stock
2018-03-15
4
S
0
22290
52.23
D
210138
D
Common Stock
2018-03-15
4
S
0
13804
53.08
D
196334
D
Stock Option (Right to Buy)
53.75
2018-03-14
4
A
0
38000
0.00
A
2028-03-14
Common Stock
38000
38000
D
Stock Option (Right to Buy)
29.66
2018-03-15
4
M
0
22094
0.00
D
2025-03-04
Common Stock
22094
20042
D
Stock Option (Right to Buy)
19.39
2018-03-15
4
M
0
14000
0.00
D
2026-02-22
Common Stock
14000
46000
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $54.15 to $55.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2019, and the remainder vests in equal amounts quarterly thereafter for the following three years.
The shares were sold at prices ranging from $51.70 to $52.675. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $52.70 to $53.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.
/s/ Michael Lowenstein, Attorney-in-fact
2018-03-15